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Background: Accurately differentiating dementia subtypes, such as Alzheimer’s
disease (AD) and Lewy body disease [including dementia with Lewy bodies (DLB) and
Parkinson’s disease dementia (PDD)] is important to ensure appropriate management
and treatment of the disease. Similarities in clinical presentation create difficulties for
differential diagnosis. Simple supportive markers, such as balance assessments, may
be useful to the diagnostic toolkit. This study aimed to identify differences in balance
impairments between different dementia disease subtypes and normal aging using a
single triaxial accelerometer.
Methods: Ninety-seven participants were recruited, forming four groups: cognitive
impairment due to Alzheimer’s disease (AD group; n = 31), dementia with Lewy bodies
(DLB group; n = 26), Parkinson’s disease dementia (PDD group; n = 13), and normal
aging controls (n = 27). Participants were asked to stand still for 2 minutes in a
standardized position with their eyes open while wearing a single triaxial accelerometer
on their lower back. Seven balance characteristics were derived, including jerk
(combined, mediolateral, and anterior–posterior), root mean square (RMS; combined,
mediolateral, and anterior–posterior), and ellipsis. Mann–Whitney U tests identified the
balance differences between groups. Receiver operating characteristics and area under
the curve (AUC) determined the overall accuracy of the selected balance characteristics.
Results: The PDD group demonstrated higher RMS [combined (p = 0.001), mediolateral
(p = 0.005), and anterior–posterior (p = 0.001)] and ellipsis scores (p < 0.002) than the
AD group (AUC = 0.71–0.82). The PDD group also demonstrated significantly impaired
balance across all characteristics (p ≤ 0.001) compared to the controls (AUC = 0.79–
0.83). Balance differences were not significant between PDD and DLB (AUC = 0.69–
0.74), DLB and AD (AUC = 0.50–0.65), DLB and controls (AUC = 0.62–0.68), or AD and
controls (AUC = 0.55–0.67) following Bonferroni correction.
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 1 March 2021 | Volume 9 | Article 639337
fbioe-09-639337 March 5, 2021 Time: 15:52 # 2
Mc Ardle et al. Balance Impairments in Dementia Subtypes
Discussion: Although feasible and quick to conduct, key findings suggest that an
accelerometer-based balance during quiet standing does not differentiate dementia
disease subtypes accurately. Assessments that challenge balance more, such as gait
or standing with eyes closed, may prove more effective to support differential diagnosis.
Keywords: dementia, Alzheimer’s disease, Lewy body disease, Parkinson’s disease, balance, accelerometer,
postural control
INTRODUCTION
Assessing motor performance, such as gait and balance, in the
aging population may be a useful clinical tool for predicting
a range of clinical outcomes, such as falls risk, neurological
disorders, cognitive impairment, and mortality (Fritz and
Lusardi, 2009; Schoneburg et al., 2013; Creaby and Cole, 2018;
Buckley et al., 2019; Modarresi et al., 2019; Peel et al., 2019).
Recently, motor performance has been reported as a potential
supportive marker of differentiating Lewy body disease (LBD)
from Alzheimer’s disease (AD) (Fritz et al., 2016; Mc Ardle
et al., 2019, 2020). Identifying supportive clinical tools to
differentiate dementia subtypes, such as LBD [which includes
dementia with Lewy bodies (DLB) and Parkinson’s disease
dementia (PDD)], is of critical importance to ensure accurate
and appropriate treatment and care provision for people with
dementia (Palmqvist et al., 2009). This is particularly apparent
for people with DLB, as DLB is underdiagnosed and may be
misdiagnosed as AD due to similarities in clinical presentation
(Palmqvist et al., 2009; Kane et al., 2018). As such, quick and
easy-to-use diagnostic tools may be welcome additions to the
clinician’s toolkit.
Motor assessments that require minimal space and time
may be an avenue of interest for differential diagnosis, such as
balance assessment. Maintaining postural control (i.e., balance)
requires coordination from multiple body systems, including the
vestibular, cognitive, visual, somatosensory, and motor systems
(Mancini and Horak, 2010); balance impairments may therefore
arise from changes to the aforementioned systems, such as
neuropathology and cognitive decline. Greater sway and larger
sway velocities have been reported in both mild cognitive
impairment and dementia (Bahureksa et al., 2017), suggesting
that balance impairments may be a marker of cognitive
disorders. This is supported by the reported associations between
balance impairments with slower information processing and
greater executive dysfunction in Parkinson’s disease (PD)
(Fernandes et al., 2016).
With the advent of accelerometer-based wearable technology,
conducting balance assessments in constrained settings
such as a clinic is increasingly feasible (Mancini et al.,
2011b, 2012b). Accelerometer-based balance characteristics
are reported as useful measures of postural instability in
neurodegenerative populations such as PD (Mancini et al.,
2011a). Balance impairments may therefore be useful markers of
neurodegenerative disease type and progression, with measures
of sway jerkiness (i.e., jerk) in the mediolateral direction
significantly impaired in PD compared to controls (Mancini
et al., 2012a), and jerk, root mean square (RMS; the magnitude
of accelerometer traces), and ellipsis (the area which includes
95% of the mediolateral and anteroposterior accelerometer
trajectories) increasing as the disease progresses (Mancini et al.,
2012a; Pantall et al., 2018). However, there is a dearth of research
examining the ability of balance assessment to discriminate
between dementia disease subtypes, with only clinical measures
of balance assessment used to report worse balance performance
in LBD compared to AD and in PDD compared to DLB (Allan
et al., 2005; Fritz et al., 2016; Scharre et al., 2016).
As such, the primary aims of this study were to (1) examine
differences in the accelerometer-derived balance characteristics
between dementia disease subtypes (i.e., AD, DLB, and PDD)
and (2) between dementia disease subtypes and normal aging.
A secondary aim was to (3) explore the associations between
clinical and cognitive characteristics with balance characteristics
in dementia disease subtypes. We hypothesize that (1) Lewy body
disease groups (i.e., DLB and PDD) will demonstrate significantly
larger jerk, RMS, and ellipsis compared to AD; (2) all dementia
disease subtypes will have significantly worse postural instability
compared to controls; and (3) slower information processing,
greater executive dysfunction, worse motor performance, and
lower balance confidence will be significantly correlated with
impaired balance characteristics in all dementia disease subtypes.
MATERIALS AND METHODS
Participants
Participants with probable mild cognitive impairment (MCI)
or probable dementia due to AD, DLB, and PDD and
older adult controls were recruited to the GaitDem Study at
Newcastle University. Participants were identified by clinicians
in old age psychiatry, geriatric medicine, or neurology services,
recruited from a local research case register (the North East
DeNDRoN Case Register), or via ongoing research studies.
The inclusion/exclusion criteria can be found elsewhere (Mc
Ardle et al., 2019). All participants had capacity to consent
and provided written informed consent. The NHS Local
Research Ethics Committee, Newcastle and North Tyneside 1,
approved this study.
The disease diagnosis of all participants was verified by
two independent clinicians via review of medical notes and
assessments; disagreements were adjudicated by a third clinician.
The relevant diagnostic criteria for dementia due to AD
(McKhann et al., 2011), DLB (McKeith et al., 2017), and PDD
(Emre et al., 2007) and for MCI due to AD (Albert et al.,
2011), DLB (McKeith et al., 2020), and PDD (Litvan et al.,
2012) were applied.
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Clinical and Cognitive Assessment
Sex, age, height, and body mass were recorded. Dementia disease
stage was assessed with the Clinical Dementia Rating Scale (CDR)
(Morris, 1997). Premorbid IQ was measured with the National
Adult Reading Test (NART) (Nelson and Willison, 1991).
Comorbidities were assessed with the Cumulative Illness Rating
Scale – Geriatrics (CIRS-G) (Linn et al., 1968), while motor
disease severity was determined using the Movement Disorders
Society Unified Parkinson’s Disease Rating Scale (MDS-UPDRS)
(Goetz et al., 2008). Functional dependence was assessed using
the Bristol Activities of Daily Living Scale (BADLS) (Bucks et al.,
1996). Balance confidence was measured using the Activities
Balance Confidence (ABC) Scale (Powell and Myers, 1995). Faller
status was recorded (i.e., if the participant had experienced a fall
within the previous 12 months).
Global cognition was measured using both the standardized
Mini Mental State Examination (sMMSE) (Molloy and Standish,
1997) and the Addenbrooke’s Cognitive Examination III
(ACE-III) (Noone, 2015), which has subscales measuring
attention, language, memory, fluency, and visuospatial abilities.
Information processing speed was assessed using the Trail
Making Test A (TMT-A) (Bowie and Harvey, 2006). The F-A-
S Verbal Fluency test assessed verbal fluency and executive
function (Borkowski et al., 1967), and the computerized simple
reaction time test measured attention.
Balance Assessment
A small accelerometer-based wearable (Axivity AX3, York,
United Kingdom; dimensions, 23.0 mm × 32.5 mm × 7.6 mm;
weight, 11 g; accuracy, 20 ppm; sampling frequency, 100 Hz)
was attached to the participants’ lower back in the L5 position
using a double-sided hydrogel adhesive and a Hypafix medical
plaster. Participants were asked to stand with heels 10 cm apart,
maintaining an upright position with arms by their sides and eyes
open for 2 min. Participants wore shoes during the assessment.
Researchers stood close by in case of adverse events.
Following assessment, the data were downloaded to a
computer and processed with a customized MATLAB R© script.
Accelerations in the anteroposterior and mediolateral planes
were of particular interest. Data were filtered using fourth-order
zero phase, low-pass Butterworth filter. The cutoff frequency
was 3.5 Hz (Del Din et al., 2015). Data were transformed
to a horizontal–vertical coordinate system, following which
the balance outcomes were extracted in the mediolateral,
anteroposterior, and combined directions.
Balance Characteristics
Seven balance characteristics were derived. Three characteristics
related to jerk in the mediolateral, anteroposterior, and combined
directions (i.e., the rate of change of acceleration, considered
a measure of dynamic stability) (Mancini et al., 2011b).
Three characteristics corresponded to RMS in the mediolateral,
anteroposterior, and combined directions (i.e., the magnitude of
accelerometer traces) (Mancini et al., 2011b). Ellipsis was also
derived (i.e., the area which includes 95% of the mediolateral and
anteroposterior acceleration trajectories) (Del Din et al., 2015).
Data were normalized over the duration of the standing balance
test to account for any differences in standing time.
Data Analysis
Normality of data was assessed using the Shapiro–Wilk
test and inspection of the histograms and box plots. Chi-
squared tests identified differences between groups for sex
and faller status. Kruskal–Wallis tests and one-way analysis
of variance (ANOVA) examined differences between groups
for all demographic, cognitive, and clinical variables. Mann–
Whitney U tests and independent t tests identified where the
differences lay between groups. As all balance characteristics
were not normally distributed, Kruskal–Wallis tests and Mann–
WhitneyU tests were used to identify differences between groups.
Bonferroni corrections (p ≤ 0.007) were applied to account
for multiple comparisons. There was one significant outlier
in the control group; we assessed group differences with and
without the outlier and found no difference to our interpretation
of results, so we retained this participant. Receiver operating
characteristics and area under the curve (AUC) were used
to determine the accuracy of discrete balance characteristics
and were interpreted as follows: 0.5–0.7 = low accuracy, 0.7–
0.9 = acceptable accuracy, and 0.9–1 = high accuracy. As the
data were not normally distributed, Spearman’s correlations were
used to explore associations between balance impairments and
the demographic, clinical, and cognitive measures.
RESULTS
Demographics
One hundred twenty-five participants were recruited to the study;
97 participants were included in this analysis. The reasons for
exclusion were as follows: clinical diagnosis other than AD, DLB,
PDD, or control (vascular dementia = 7, non-dementia = 4,
control with suspected cognitive impairment = 1), withdrawal
from the study (n = 3), and inability to complete the balance
assessment (n = 13).
As the dementia disease groups included people with MCI
or dementia (see Table 1), we initially examined the differences
in balance characteristics within each dementia disease group,
comparing MCI and dementia. As there were no significant
differences found between MCI and dementia within each
subtype, it was deemed feasible to include both disease stages
within each dementia disease group (i.e., AD, DLB, and
PDD). The demographics and clinical and cognitive information
are illustrated in Table 1, with significant between-group
differences reported.
Differences in Balance Characteristics
Between Dementia Disease Subtypes
Compared to the AD group, the PDD group demonstrated
significantly larger jerk in the combined, anteroposterior
(AP), and mediolateral (ML) directions (see Tables 2, 3 for
statistical significance), larger RMS in the combined, ML, and
AP directions, and larger ellipsis (see Figure 1). They also
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TABLE 1 | Demographics and clinical and cognitive data for dementia disease groups and controls.
Controls AD DLB PDD p Between-group differences
n 27 31 26 13
Age (years) 74 ± 9 77 ± 6 76 ± 6 79 ± 6 0.326
Sex (male/female) 11/16 14/17 22/4 12/1 <0.001 a, b, c, d, e
NART 123 (117–126) 117 (101–125) 116 (101–124) 121 (105–124) <0.001 a, b, c
CIRS-G 4 (0–11) 8 (3–16) 10 (5–16) 10 (3–17) <0.001 a, b, c, d, e
MDS-UPDRS III 1 (0–11) 7 (0–19) 26 (0–57) 40 (20–70) <0.001 a, b, c, d, e
Faller status (%) 20% 45% 59% 69% 0.009 a, b, c
ABC (%) 94 (52–100) 90 (37–100) 86 (42–100) 75 (21–94) <0.001 a, b, c, e
% Mild cognitive impairment N/a 39 33 46 0.732
% Dementia N/a 61 67 54 0.732
sMMSE (/30) 30 (25–30) 23 (14–29) 24 (16–30) 24 (12–30) <0.001 a, b, c
ACE-III Total (/100) 97 (87–100) 74 (48–90) 75 (15–95) 79 (49–95) <0.001 a, b, c
ACE-III Attention (/18) 18 (17–18) 14 (6–18) 15 (8–18) 14 (7–18) <0.001 a, b, c
ACE-III Memory (/26) 25 (19–26) 14 (6–23) 17 (0–26) 20 (9–26) <0.001 a, b, c, d, e
ACE-III Fluency (/14) 13 (5–14) 9 (2–13) 8 (3–13) 7 (2–12) <0.001 a, b, c
ACE-III Language (/26) 26 (24–26) 23 (11–26) 23 (0–26) 25 (17–26) <0.001 a, b, c
ACE-III Visuospatial (/16) 16 (13–16) 14 (6–16) 12 (0–16) 11 (9–16) <0.001 a, b, c, d, e
FAS (n) 47 (29–75) 35 (3–61) 31 (7–58) 19 (11–48) <0.001 a, b, c, e
TMT-A (s) 30 (19–65) 51 (29–306) 109 (28–835) 95 (24–955) <0.001 a, b, c, d, e
RT Single Task (ms) 373 (291–493) 415 (287–773) 446 (287–1,071) 558 (387–3,792) <0.001 a, b, c, d, e
Data displayed as mean ± SD were analyzed using one-way ANOVA and post hoc t tests. Data displayed as median (min–max) were analyzed using Kruskal–Wallis
tests and post hoc Mann–Whitney U tests. Significant differences are as follows: a = controls vs. AD, b = controls vs. DLB, c = controls vs. PDD, d = AD vs. DLB, and
e = AD vs. PDD. AD, Alzheimer’s disease; DLB, dementia with Lewy bodies; PDD, Parkinson’s disease dementia; NART, National Adult Reading Test; CIRS-G, Cumulative
Illness Rating Scale – Geriatrics; MDS-UPDRS III, Movement Disorders Society Unified Parkinson’s Disease Rating Scale; ABC, Activities Balance Confidence Scale;
sMMSE, standardized Mini Mental State Examination; ACE-III, Addenbrooke’s Cognitive Examination III; FAS, FAS Verbal Fluency Test; TMT-A, Trail Making Task Part A;
RT, reaction time. Bold p-values indicate statistically significant results.
demonstrated significantly larger RMS ML compared to the
DLB group. No differences were found between the AD and
DLB groups. When Bonferroni corrections were applied, only
differences in RMS, RMS AP, and ellipsis remained statistically
significant between the AD and PDD groups. ROC curve analysis
demonstrated acceptable–excellent accuracy to discriminate
PDD from AD (AUC = 0.71–0.82), acceptable accuracy to
discriminate PDD from DLB (AUC = 0.69–0.74), and low
accuracy to discriminate DLB from AD (AUC = 0.50–0.65) for
all balance characteristics (see Table 3).
Differences in Balance Characteristics
Between Dementia Disease Subtypes
and Controls
Compared to the controls, both the PDD and DLB groups
demonstrated significantly larger jerk in the combined, AP,
and ML directions, larger RMS in the combined and AP
directions, and larger ellipsis (see Tables 2, 3 and Figure 1).
The PDD group also demonstrated greater RMS ML compared
to the controls. The AD group had greater jerk AP compared
to the controls. When Bonferroni corrections were applied,
only differences between the controls and PDD for all
characteristics remained statistically significant. ROC curve
analysis demonstrated excellent accuracy to discriminate PDD
(AUC = 0.79–0.83) from the controls and low accuracy to
discriminate AD (AUC = 0.55–0.67) and DLB (AUC = 0.62–0.68)
from the controls for all balance characteristics (see Table 3).
Associations Between Balance
Characteristics and Clinical and
Cognitive Measures in Dementia Disease
Subtypes
Alzheimer’s Disease
In AD, older age was associated with greater combined
(rho = 0.424, p = 0.018) and AP RMS (rho = 0.438, p = 0.014) and
larger ellipsis (rho = 0.404, p = 0.024). Greater motor problems,
as measured by UPDRS-III, was associated with greater RMS AP
(rho = 0.428, p = 0.018; see Figure 2). Worse verbal fluency, as
measured by ACE-III Fluency, was significantly associated with
greater combined (rho = 0.422, p = 0.018), ML (rho = 0.406,
p = 0.024), and AP jerk (rho = 0.426, p = 0.017), greater combined
(rho = 0.373, p = 0.039) and ML RMS (rho = 0.369, p = 0.041),
and larger ellipsis (rho = 0.378, p = 0.036). Similar findings
were found between the FAS verbal fluency test with jerk AP
(rho = 0.377, p = 0.037) and RMS ML (rho = 0.374, p = 0.038).
Slower information processing, as measured by TMT-A, was
significantly associated with greater combined (rho = 0.461,
p = 0.009), ML (rho = 0.416, p = 0.020), and AP jerk (rho = 0.454,
p = 0.010).
Dementia With Lewy Bodies
In DLB, better visuospatial abilities (rho = 0.423, p = 0.035),
as measured by the ACE-III visuospatial subscale, and quicker
information processing (rho = 0.539, p = 0.026) were associated
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TABLE 2 | Balance differences between dementia disease groups and controls.






n 27 31 26 13
Jerk combined (m2 s−6) 0.063 (0.027–3.942) 0.075 (0.038–0.383) 0.080 (0.023–0.726) 0.203 (0.050–1.10) 0.003 a
Jerk ML (m2 s−6) 0.029 (0.006–2.669) 0.030 (0.013–0.180) 0.037 (0.002–0.414) 0.062 (0.019–0.625) 0.008
Jerk AP (m2 s−6) 0.035 (0.016–1.274) 0.044 (0.024–0.202) 0.047 (0.019–0.312) 0.109 (0.031–0.471) 0.002 a
RMS combined (m s−3) 0.0008 (0.0004–0.0061) 0.0009 (0.0006–0.0027) 0.0012 (0.0006–0.0039) 0.0022 (0.0005–0.0044) 0.001 a, b
RMS ML (m s−3) 0.0004 (0.0001–0.0039) 0.0005 (0.0003–0.0016) 0.0005 (0.0001–0.0019) 0.0012 (0.0004–0.0023) 0.006 a, b
RMS AP (m s−3) 0.0007 (0.0004–0.0049) 0.0008 (0.0006–0.0022) 0.0011 (0.0006–0.0034) 0.0018 (0.0004–0.0039) 0.001 a, b
Ellipsis (m2 s−5) 0.0007 (0.0001–0.0410) 0.0008 (0.0004–0.0061) 0.0011 (0.0001–0.0142) 0.0043 (0.0003–0.0116) 0.001 a, b
Data are reported as median (minimum–maximum). Kruskal–Wallis tests were used to identify differences between groups. Mann–Whitney U tests were used to identify
where differences lay. Bonferroni correction (p < 0.007) applied. Significant differences are as follows: a = PDD vs. controls and b = PDD vs. AD. ML, mediolateral; AP,
anteroposterior; RMS, root mean square. Bold p-values indicate statistically significant results.
TABLE 3 | Area under the curve values of discrete balance characteristics between groups based on receiver operator curve analysis.
AD vs. DLB AD vs. PDD PDD vs. DLB
Area p CI lower CI upper Area p CI lower CI upper Area p CI lower CI upper
Jerk combined 0.531 0.689 0.377 0.685 0.73 0.017 0.55 0.909 0.698 0.046 0.511 0.886
Jerk ML 0.545 0.564 0.391 0.699 0.722 0.021 0.538 0.907 0.695 0.049 0.512 0.878
Jerk AP 0.535 0.654 0.381 0.689 0.715 0.026 0.531 0.898 0.692 0.053 0.502 0.883
RMS combined 0.655 0.045 0.503 0.807 0.811 0.001 0.63 0.992 0.734 0.019 0.546 0.922
RMS ML 0.574 0.336 0.418 0.731 0.779 0.004 0.608 0.95 0.731 0.02 0.546 0.915
RMS AP 0.656 0.044 0.505 0.807 0.824 0.001 0.649 0.999 0.743 0.015 0.557 0.928
Ellipsis 0.624 0.109 0.471 0.778 0.804 0.002 0.624 0.984 0.71 0.034 0.524 0.896
AD vs. Controls DLB vs. Controls PDD vs. Controls
Area p CI lower CI upper Area p CI lower CI upper Area p CI lower CI upper
Jerk combined 0.652 0.047 0.51 0.794 0.682 0.023 0.534 0.831 0.821 0.001 0.667 0.974
Jerk ML 0.626 0.1 0.481 0.771 0.67 0.034 0.518 0.821 0.792 0.003 0.613 0.971
Jerk AP 0.675 0.022 0.534 0.816 0.687 0.02 0.539 0.834 0.838 0.001 0.707 0.968
RMS combined 0.558 0.45 0.406 0.71 0.695 0.015 0.552 0.839 0.818 0.001 0.646 0.989
RMS ML 0.584 0.272 0.435 0.734 0.628 0.109 0.472 0.785 0.795 0.003 0.626 0.963
RMS AP 0.56 0.431 0.408 0.713 0.684 0.022 0.538 0.83 0.823 0.001 0.657 0.99
Ellipsis 0.578 0.307 0.43 0.727 0.668 0.036 0.517 0.819 0.826 0.001 0.664 0.988
Bonferroni correction (p < 0.007) applied. Bold p-values indicate statistically significant results.
with greater jerk ML (see Figure 2). Worse verbal fluency was
associated with greater jerk AP (rho = 0.433, p = 0.035).
Parkinson’s Disease Dementia
In PDD, worse balance confidence, as measured by the ABC scale,
was associated with greater jerk ML (rho = 0.578, p = 0.039; see
Figure 2). Slower information processing was associated with
greater RMS ML (rho = 0.566, p = 0.044).
DISCUSSION
This is the first study to examine the differences in accelerometer-
derived balance characteristics between dementia disease
subtypes and normal aging. The key results demonstrate that
people with PDD could be discriminated with acceptable
accuracy from both people with AD and cognitively intact older
adults based on balance impairments. However, differentiating
between DLB and AD is more clinically challenging, and
therefore, discriminative markers for these groups are considered
a research priority (Kane et al., 2018). Our results demonstrated
that balance assessment could not acceptably discriminate
DLB from any other subtype, nor could it differentiate normal
aging from AD or DLB.
Balance Assessment as a Differential
Marker of Dementia Disease Subtype
In partial agreement with hypothesis 1, the PDD group
demonstrated greater RMS in the combined and mediolateral
directions and larger ellipsis compared to people with AD. This is
consistent with findings from clinical measures (Allan et al., 2005;
Fritz et al., 2016; Scharre et al., 2016). However, no differences
were found between DLB and either AD or PDD once multiple
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FIGURE 1 | Illustration of balance data across dementia disease subtypes and controls. AD, Alzheimer’s disease; DLB, dementia with Lewy bodies; PDD,
Parkinson’s disease dementia; ML, mediolateral; AP, anteroposterior; RMS, root mean square. Dots denote outliers.
comparison corrections were applied. Although this is the first
study to quantitatively examine balance impairments across
dementia disease subtypes, these findings contrast with findings
of significant differences in balance performance between all
three dementia subtypes when assessed with an observational
clinical measure (i.e., the Tinetti Balance subscale) (Allan et al.,
2005; Fritz et al., 2016; Scharre et al., 2016). Confirmation bias
introduced by clinical measures may explain the discrepancy in
the findings, as examiners may subjectively expect greater balance
problems in cohorts with clinically defined motor problems such
as LBD (Emre et al., 2007; McKeith et al., 2017) compared to
conditions that are not traditionally considered to have motor
impairments such as AD (Allan et al., 2005). Based on our results,
we do not recommend an eyes-open accelerometer-based balance
assessment as a differential tool for AD and DLB.
Balance Assessment as a Differential
Marker of Cognitive Impairment
In disagreement with hypothesis 2, only the PDD group
demonstrated significant differences across all balance
characteristics compared to cognitively intact controls. These
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FIGURE 2 | Examples of the associations between clinical and cognitive variables with balance characteristics. (A) ACE-III Fluency associated with jerk vertical in AD
(rho = 0.422, p = 0.018). (B) TMT-A associated with jerk ML in AD (rho = 0.416, p = 0.020) and DLB (rho = 0.539, p = 0.035). (C) ABC associated with jerk ML in
PDD (rho = 0.578, p = 0.039). (D) FAS associated with jerk AP in AD (rho = 0.377, p = 0.037) and DLB (rho = 0.433, p = 0.035). (E) FAS associated with RMS ML in
AD (rho = 0.374, p = 0.038). (F) TMT-A is associated with RMS ML in PDD (rho = 0.566, p = 0.044). (G) MDS UPDRS-III is associated with RMS AP in AD
(rho = 0.428, p = 0.018). (H) ACE-III Fluency is associated with ellipsis in AD (rho = 0.378, p = 0.036). AD, Alzheimer’s disease; DLB, dementia with Lewy bodies;
PDD, Parkinson’s disease dementia; ML, mediolateral; AP, anteroposterior; RMS, root mean square; ACE-III, Addenbrooke’s Cognitive Examination; TMT-A, Trail
Making Test A; ABC, Activities Balance Confidence Scale; FAS, FAS Verbal Fluency Test; MDS-UPDRS III, Movement Disorders Society Unified Parkinson’s Disease
Rating Scale. Dots denote outliers.
results support previous findings that accelerometer-based
balance assessment is useful for differentiating PD from normal
aging and for monitoring disease progression and cognitive
decline in people with PD (Mancini et al., 2012a; Schoneburg
et al., 2013; Del Din et al., 2015; Pantall et al., 2018). However,
static eyes-open balance assessment did not appear significantly
impaired in other dementia disease subtypes and, therefore,
may not be a good marker of general cognitive impairment; this
contrasts previous literature (Bahureksa et al., 2017). It should be
noted that our cohort was a predominately mild dementia group,
composed of both MCI and dementia participants, and this
may have impacted our results. The review of Bahureksa et al.
(2017) found limited differences in static balance performance
in the MCI groups compared to normal aging in eyes-open
conditions, suggesting that these groups use visual feedback to
appropriately maintain their postural stability. As such, balance
differences under these conditions may be apparent in the
later stages of dementia disease. However, this is not useful
to support early diagnosis of cognitive impairment, which is
required to better manage the condition, ensure patients and
carers can appropriately plan for the future, and to improve
researchers’ understanding of early disease stages in order to
develop novel targets for therapeutics (Kenigsberg et al., 2016).
We therefore suggest alternative motor performance measures
to support differential diagnosis. For example, gait assessment
has demonstrated acceptable accuracy to discriminate AD and
DLB and may therefore be an effective easy-to-use supportive
diagnostic marker (Mc Ardle et al., 2019, 2020).
Relationships Between Discrete Clinical
and Cognitive Characteristics With
Balance
To aid interpretation of the results, we examined associations
between clinical and cognitive measures with balance
performance. Partially agreeing with hypothesis 3, correlations
were found between cognitive impairments and balance
impairments. This was most apparent in the AD group, with
slower information processing and worse verbal fluency (often
considered a measure of executive function) (Williams-Gray
et al., 2009) associated with poor balance performance. This
is supported by the literature in PD (Fernandes et al., 2016),
suggesting that balance relies on these discrete cognitive
processes to maintain postural stability. For example, executive
function may be important for planning and set-shifting
during standing balance and may inhibit inappropriate postural
responses (Schoneburg et al., 2013). Interestingly, associations
between greater motor disease and worse balance were only
found in the AD group, and associations between worse balance
confidence and balance were only found in the PDD group;
however, trends indicated similar directionality in all groups (see
Figure 2). As the PDD group demonstrated significantly slower
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information processing, worse verbal fluency, greater motor
disease burden, and worse balance confidence compared to the
AD group, this may somewhat account for their poorer balance
performance. Overall, static balance may not be challenging
to cognitive and motor abilities, particularly in lab-based
environments which lack complexities experienced in the real
word that may increase cognitive demands, such as constrained
spaces, moving objects, and visual stimuli. The results may
have been different if static balance performance was examined
under different conditions. For example, eyes-closed static
balance assessments increase reliance on the vestibular system
and decreases compensatory visual and cognitive input for the
maintenance of balance, potentially revealing greater balance
impairments (Schoneburg et al., 2013; Bahureksa et al., 2017).
Similarly, static balance assessments on uneven surfaces have
demonstrated significantly worse balance in AD compared to
normal aging (Suttanon et al., 2012). Standing statically on
uneven surfaces, such as foam, requires consistent and quick
postural adaptions to maintain balance (yeun Lee et al., 2011)
and may reveal significant impairments when participants have
discrete cognitive deficits, such as slower information processing
that slows their anticipatory postural adjustments. Other studies
have also employed cognitive dual tasks to static balance
assessment in people with AD (Manckoundia et al., 2006). This
places competition on cognitive resources, as participants are
trying to maintain balance while carrying out an additional
cognitive task, and produces greater balance impairments
compared to single-task balance assessments. Future research
could consider the impact of different conditions such as those
outlined on balance in people with cognitive impairments.
However, the findings from this study suggest that eyes-open
static balance assessments will not be useful additions to the
diagnostic toolkit.
Limitations and Directions for Future
Research
A main strength of this study was that all participants’ diagnoses
were confirmed by clinicians’ consensus based on clinical notes
and well-characterized clinical and cognitive profiles. However,
while this lends confidence to our results, diagnosis of dementia
subtype can only be confirmed postmortem, which was beyond
the scope of this study. We also looked at groups across the
spectrum of cognitive impairment, which was deemed feasible
as the MCI and dementia participants were indistinguishable
in terms of balance impairments. However, there are limits
to this approach; although we applied validated criteria for
MCI due to dementia disease subtype (Litvan et al., 2012;
McKeith et al., 2020), not all MCI participants may progress
to dementia, and it was beyond the scope of this study to
determine whether participants with MCI due to Lewy body
disease went on to develop DLB or PDD. Additionally, although
this is the first study of its kind, our sample size was small,
causing difficulties to the generalizability of the findings, and
outliers may have affected the results. Raw data were checked
to ensure that outlier data were correct, highlighting the skewed
distribution of balance performance. As our data were not
normally distributed, we used non-parametric analysis to explore
differences between groups. This limited our ability to account
for potential confounders, such as age and sex, which may
have improved our interpretation of results. Larger studies are
required to account for these issues with generalizability and
skewed distribution and would strengthen the findings described
here. Our results suggest that a 2-min static eyes-open balance
assessment is not a useful differential marker of dementia
disease subtype or cognitive impairment. Studies in PD have
indicated that balance impairments may be time-dependent,
with shorter bouts producing more sensitive results (Del Din
et al., 2015). However, we examined postural stability across
different bout lengths (e.g., <30 and <60 s) and found that
it did not change our interpretation. Additionally, we did not
assess visual acuity in this study. As vision plays a significant
role in the maintenance of balance, our lack of insight into
participants’ visual acuities is considered a limitation (Hill et al.,
2016; Baydan et al., 2020; Hunter et al., 2020). To ensure
participant safety, a researcher stood close to the participants
who were visibly unstable or worried about their balance; this
may also have influenced the results as it provided more security
and confidence for the participants. It should be noted that
static balance is only one element of balance; dynamic balance
assessments require faster postural adjustments and may be
significantly more compromised by cognitive impairments (Liaw
et al., 2009). As we did not assess dynamic balance, we cannot
draw conclusions on the efficacy of such assessments to detect
cognitive impairment or dementia disease subtype. Finally, there
is growing interest in classification methods, such as machine
learning, which involve combining different disease features and
assessing the best combinations for discriminating diseases. In
the future, these methods could be applied in larger studies to
combinations of balance characteristics, such as those described
in this article, or to a combination of balance characteristics
with other motor performance measures, such as gait or dynamic
balance performance.
CONCLUSION
In conclusion, this study found that static eyes-open balance
assessments could only acceptably differentiate PDD from AD
and controls. Static eyes-open balance assessment is not a
useful differential marker of AD and DLB or for distinguishing
general cognitive impairment from normal ageing. In line with
previous work in PD, associations were found between slower
information processing and greater executive dysfunction with
balance impairments, suggesting that cognition may play a role
in safely maintaining balance. Future research could examine the
impact of alternative conditions, such as eyes closed or dual tasks,
on balance across dementia disease subtypes as this may prove a
more fruitful endeavor.
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